Atlas Trials

Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance

Clinical trial NCT06653062 · RECRUITING

Trial details

NCT number
NCT06653062
Sponsor
Tongji Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Hepatocellular Carcinoma (HCC)
Start date
2024-11-18
Primary completion
2027-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.